Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Elizabeth A. Chrischilles"'
Autor:
Eric M. Ammann, Elizabeth A. Chrischilles, Melissa C. Larson, Kara B. Wright, Brian K. Link, Bradley D. McDowell, Tait D. Shanafelt
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 17:e11-e25
Background Novel targeted therapies offer excellent short-term outcomes in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL/SLL). However, there is disagreement over how widely these therapies should be used in place of
Autor:
James J. Mezhir, Anna M. Button, Bradley D. McDowell, Cole G. Chapman, Brian J. Smith, Elizabeth A. Chrischilles
Publikováno v:
Annals of Surgery. 261:740-745
Pancreatic resection is the standard treatment option for patients with stage I/II pancreatic ductal adenocarcinoma (PDA), yet many studies demonstrate low rates of resection. The objective of this study was to evaluate whether increasing resection r
Autor:
Bradley D. McDowell, Elizabeth A. Chrischilles, Neeraj K. Arora, Mary E. Charlton, Linda M. Rubenstein, Grelda Yazmin Juarez, Jane F. Pendergast
Publikováno v:
Journal of Cancer Survivorship. 9:269-278
This study aims to evaluate the relationship between survivorship care planning (SCP) and survivorship care and health outcomes reported by long-term lung and colorectal cancer survivors. Participants (n = 832) were diagnosed and enrolled during 2003
Autor:
Elizabeth A. Chrischilles, Karyn B. Stitzenberg, Robert B. Wallace, Mary E. Charlton, Thorvardur R. Halfdanarson, Chi Lin, Dingfeng Jiang, Jane F. Pendergast
Publikováno v:
American Journal of Clinical Oncology. 36:572-579
PURPOSE Preoperative (preop) chemoradiation therapy (CRT) improves local control and reduces toxicity more than postoperative (postop) CRT for the treatment of stages II/III rectal cancer, but studies suggest that many patients still receive postop C
Autor:
Jennifer Malin, Aileen B. Chen, James A. Hayman, Jane C. Weeks, Angel M. Cronin, Elizabeth A. Chrischilles, Deborah Schrag
Publikováno v:
Journal of Clinical Oncology. 31:558-564
Purpose Randomized data suggest that single-fraction or short-course palliative radiation therapy (RT) is sufficient in the majority of patients with metastatic cancer. We investigated population-based patterns in the use of palliative RT among patie
Autor:
Jane C. Weeks, Jennifer Malin, Benjamin Kim, Elizabeth A. Chrischilles, Arnold L. Potosky, Nadia Howlader, Solomon B. Makgoeng
Publikováno v:
JNCI Journal of the National Cancer Institute. 103:979-982
Myeloid colony-stimulating factors (CSFs) decrease the risk of febrile neutropenia (FN) from high-risk chemotherapy regimens administered to patients at 20% or greater risk of FN, but little is known about their use in clinical practice. We evaluated
Publikováno v:
Leukemialymphoma. 56(1)
Anthracycline-containing regimens (ACRs) are recommended for patients with diffuse large B-cell lymphoma (DLBCL). However, over 40% of elderly patients do not receive ACRs, possibly due to expected toxicities. We characterized treatment choices and c
Autor:
John M. Brooks, Brian K. Link, X. Pan, Kara B. Wright, Elizabeth A. Chrischilles, Margaret D. Voelker
Publikováno v:
Leukemialymphoma. 52(6)
Anthracycline-based chemotherapy (ABC) is the most effective therapy for diffuse large B-cell lymphoma (DLBCL). The addition of rituximab to ABC in controlled trials has demonstrated superior survival, yet ABC is inconsistently utilized in elderly pa
Autor:
Mary Beth Landrum, Nancy L. Keating, Eric P. Winer, Elizabeth A. Chrischilles, Kara B. Wright, Rita Volya, John M. Brooks
Recent studies suggest trends toward more mastectomies for primary breast cancer treatment. We assessed survival after mastectomy and breast-conserving surgery (BCS) with radiation for early-stage breast cancer among non-selected populations of women
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ef9f344cea88abef714af6b7d325ec2
https://europepmc.org/articles/PMC2924956/
https://europepmc.org/articles/PMC2924956/
Autor:
Elizabeth A. Chrischilles, Jane F. Pendergast, Dee W. West, Katherine L. Kahn, David P. Harrington, Daniela C. Moga, Robert B. Wallace, Jane C. Weeks, Robert H. Fletcher, Catarina I. Kiefe, S. Yousuf Zafar
Purpose To describe chemotherapy use and adverse events (AEs) for advanced-stage, non–small-cell lung cancer (NSCLC) in community practice, including descriptions according to variation by age. Methods We interviewed patients with newly diagnosed,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5f55baf895a0274a8bab1ba8cc1fa0d
https://europepmc.org/articles/PMC2815997/
https://europepmc.org/articles/PMC2815997/